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Investigations into the Integration of Nucleotide Sequences of the 
Reticuloendotheliosis Provirus into the Genome of Fowlpox Virus
The first aim of this study was to find out by molecularbiological methods to which extent 
REV–specific DNA was integrated into the DNA of fowlpox virus (FPV) that caused field–
outbreaks in Germany during the recent years. For this purpose a multiplex–PCR, which 
detects the gene of the 4b–core–protein of FPV as well as gag–, pol– und env–genes of REV 
and the long terminal repeats of REV, was established. In most investigated DNAs the four 
sequences specific for REV were detected. Additionally a chimeric FPV–REV–PCR–product 
was found in most DNAs. This indicates the presence of an integrated, almost complete 
REV–provirus (fvRP). In addition three DNAs were investigated further by long–distance–
PCR to confirm this. The detection of the integrated fvRP was not possible with primers 
specific for FPV that flank the integration site of the fvRP, but only with primers specific for 
the LTR of REV. By adjacent restriction enzyme analysis the result was confirmed. 
Furthermore the integration site of the fvRP in a field–DNA and in the vaccine strain HP B as 
well as the chimeric FPV–REV–PCR–product from the field–DNA were sequenced. By these 
means a remnant of the LTR of about 300bp was detected also in the vaccine strain. 
Comparison of all three obtained sequences with published sequences showed only one 
single base–pair substitution. This demonstrated a high conservation of the integration site of 
FPV–strains from three continents. 
A qPCR was established to determine the ratio between DNA specific for FPV and DNA 
specific for REV in some field–DNAs and in different passages in vitro of a field isolate. In all 
investigated field–DNAs the FPV subpopulation with integrated fvRP predominated. When 
passaged in vitro, the field isolate lost the fvRP at a rate of about 0.5 (50%) until the 16th
passage. After 32 passages no DNA specific for REV was detectable by PCR. 
Further extensive serological investigations of field sera for antibodies against FPV and 
REV were carried out. As there was no commercial ELISA available for the detection of 
antibodies against FPV, an indirect ELISA for this purpose was established. The sensitivity 
was 85.3%, the specificity 100%. Afterwards the repeatability of the obtained results of the 
ELISA was tested. The intraassay–coefficients showed a good repeatability. The interassay–
coefficients were not satisfying. One explanation was an insufficient stability of the coating 
antigen when partly used plates were stored at 4°C resp. frozen a second time. In 
comparison to other methods for detecting antibodies against FPV the ELISA was marginally 
less sensitive than indirect immunfluorescence and more sensitive than AGP. 
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The investigation of sera from flocks that were exposed to natural infection with FPV for 
antibodies against FPV and REV showed a proportion of about 50% with antibodies against 
FPV and a higher proportion with antibodies against REV. There were some differences 
between the flocks. A similar proportion of sera from flocks that were vaccinated against FPV 
had antibodies against FPV, but only in two of ten investigated flocks chickens had 
antibodies against REV. This makes clear, that the REV–antibodies were induced by the 
integrated fvRP and not by an accidental coinfection with REV. This also shows that most of 
German FPV–strains are able to induce antibodies against REV. 
Two experimental infection studies were done to investigate the humoral immune 
response against FPV and REV after intracutaneous infection with different in vitro passages 
of a field isolate and with the vaccine strain HP B. In both trials the low passaged field isolate 
with the integrated fvRP induced no antibodies against FPV. The proportion of birds with 
antibodies against REV varied depending on the infection dose. In contrast to that the 
vaccine strain induced antibodies against FPV in all birds but not against REV independently 
from the infecting dose. The highly passaged field isolate, in which the fvRP could not be 
found by PCR, induced antibodies against FPV only in a few birds and no antibodies against 
REV. So it was assumed, that the integrated fvRP contributes to the suppression of the 
antibody response against FPV after an infection with a field isolate. In the first trial the birds 
were reinfected after five weeks by intravenous application of the low passaged field isolate. 
About half the birds that previously had been infected with the field isolate developed 
antibodies against FPV. The proportion of birds with antibodies against REV increased 
marginally. The birds that had been vaccinated previously showed no antibody response 
against REV. The reason for this may be that the vaccination prevented the replication of the 
FPV field isolate and so the development of antibodies. After the intracutaneous infection 
with the low passaged field isolate and after the intravenous reinfection DNA specific for REV 
was detected in the peripheral blood mononuclear cells. FPV–DNA could only be detected in 
one of all examined samples. This indicates that infectious REV–virions can be formed from 
the FPV field isolate with integrated fvRP. 
